The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease.

Paik JM, Deshpande R, Golabi P, Younossi I, Henry L, Younossi ZM.
Aliment Pharmacol Ther. 2019 Nov 29. doi: 10.1111/apt.15580.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?

Metabolic Continuum Roundtable
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.